CollaFibR 3D scaffold
Commercial- Indications
- Tissue engineering
Company intelligence / Profile preview
3D BioFibR has developed a patented dry-spinning platform that enables the commercial-scale production of collagen fibers and other biopolymers with properties closely mimicking natural tissues. Their products are used in advanced cell culture, tissue engineering, and bioprinting applications. The company is establishing clinical partnerships but does not have clinical trial results as it is primarily a biomaterials supplier[4][6].
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 3D BioFibR.